-+ 0.00%
-+ 0.00%
-+ 0.00%

Market Chatter: H. Lundbeck Said to Eye Xeris Biopharma Acquisition

MT Newswires·09/30/2026 05:22:09
Listen to the news
05:22 AM EDT, 09/30/2026 (MT Newswires) -- H. Lundbeck (HLUN-A.CO, HLUN-B.CO) is working with advisers to evaluate its potential acquisition of US drugmaker Xeris Biopharma, Bloomberg News reported Tuesday, citing people familiar with the matter. However, there is no assurance that the Danish biopharmaceutical company will pursue a deal, the sources added. H. Lundbeck and Xeris Biopharma did not immediately respond to requests for comment from MT Newswires. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)